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RESEARCH ARTICLE
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Abstract
The complex life cycle of oncogenic human papillomavirus (HPV) initiates in undifferentiated
basal epithelial keratinocytes where expression of the E6 and E7 oncogenes is restricted.
Upon epithelial differentiation, E6/E7 transcription is increased through unknown mecha-
nisms to drive cellular proliferation required to support virus replication. We report that the
chromatin-organising CCCTC-binding factor (CTCF) promotes the formation of a chromatin
loop in the HPV genome that epigenetically represses viral enhancer activity controlling E6/
E7 expression. CTCF-dependent looping is dependent on the expression of the CTCF-
associated Yin Yang 1 (YY1) transcription factor and polycomb repressor complex (PRC)
recruitment, resulting in trimethylation of histone H3 at lysine 27. We show that viral onco-
gene up-regulation during cellular differentiation results from YY1 down-regulation, disrup-
tion of viral genome looping, and a loss of epigenetic repression of viral enhancer activity.
Our data therefore reveal a key role for CTCF-YY1–dependent looping in the HPV life cycle
and identify a regulatory mechanism that could be disrupted in HPV carcinogenesis.
Author summary
Oncogenic human papillomavirus (HPV) infection causes cancers of the anogenital and
oropharyngeal tracts. HPV infects undifferentiated basal cells of the epithelium at these
body sites and expresses low levels of viral early genes, required for replication of the viral
genome. In normal epithelia, cellular migration away from the basal layer induces cell
cycle exit and differentiation. However, in an HPV-infected cell, differentiation induces
increased transcription of the viral early genes to prevent cell cycle exit, supporting ampli-
fication of the viral DNA. In this study, we show that the HPV genome recruits the cellular
transcriptional regulators CTCF and YY1, which coordinate an epigenetically repressed
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chromatin loop between the YY1-bound viral transcriptional enhancer and CTCF-bound
early gene region to attenuate early gene expression in undifferentiated cells. As the cells
differentiate, YY1 protein expression and recruitment to the viral genome is dramatically
reduced. This results in a loss of chromatin loop formation, epigenetic de-repression of
the viral genome, and enhanced viral early gene expression. The coordination of viral
gene expression with cellular differentiation is vital for persistence of infection and com-
pletion of the virus life cycle, and disruption of HPV transcriptional control is also a key
step in the development of cancer.
Introduction
Human papillomaviruses (HPVs) are a family of small, double-stranded DNA viruses that
infect epithelia at specific anatomical sites. Infection with any of the 12 mucosal oncogenic
HPV types is a risk factor for the development of epithelial cancers such as cancer of the uter-
ine cervix and oropharynx [1]. The majority of these epithelial cancers are caused by infection
with the HPV16 and 18 viral subtypes.
The HPV life cycle is dependent on the differentiation of infected keratinocytes. Infection is
established in the undifferentiated basal cells of epithelia, allowing the virus access to the cellu-
lar DNA replication machinery required to replicate viral episomes. To maintain the cell in a
proliferative state, the viral E6 and E7 oncoproteins work synergistically to delay differentia-
tion and prevent cell cycle exit. These essential viral proteins are encoded by transcripts that
initiate from a short promoter situated immediately upstream of the early transcription start
site, termed P105 in HPV18 [2]. The activity of P105 is controlled by enhancer and silencer
sequences upstream of the promoter in the 850 basepair (bp) viral long control region (LCR).
P105 contains a canonical TATA box, essential for the recruitment of the general transcription
factor II D (TFIID) and the initiation of RNA polymerase II (RNA Pol II)-dependent tran-
scription [3]. Proximal to the TATA box is a keratinocyte-specific 30 enhancer, which recruits
cellular transcription activators such as Sp1 and AP-1 (Fos/Jun) [4–6]. Situated within the 30
enhancer is a silencer region that contains an array of Yin Yang 1 (YY1) binding sites. YY1
recruitment within this region has strong repressive effects on early gene transcription by the
exclusion of AP-1 binding [7,8]. It has also been shown in the related HPV31 that the tran-
scription elongation factor TEF-1 and YY1 work cooperatively to activate a second 50 distal
enhancer within the viral LCR [9], and YY1 binding at this site increases as cells differentiate
[10]. However, YY1 binding to the 50 distal enhancer has minimal effects on transcription in
HPV16 [7].
The episomal papillomavirus genome associates with histones to form nucleosomes that are
subject to epigenetic modification through the specific recruitment of cellular transcription
factors that regulate viral transcription [11]. In HPV31, levels of acetylated histone H3 and H4
within the LCR increased upon cellular differentiation, particularly in the keratinocyte-specific
enhancer, and correlated with increased transcription [10].
It is clear that epigenetic regulation of HPV transcription plays an important role in the
HPV life cycle and in enhanced viral oncogene expression during disease progression [10,12];
however, the mechanisms involved in this regulation have not been determined. We have pre-
viously shown that the chromatin-organising transcriptional insulator protein CCCTC-bind-
ing factor (CTCF) associates with oncogenic HPV16 and 18 in the E2 open reading frame
(ORF), approximately 3,000 nucleotides downstream of the viral LCR [13]. CTCF is a ubiqui-
tously expressed host-cell chromatin-binding protein that associates with tens of thousands of
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sites within the human genome [14]. Depending on the context of the binding site, CTCF can
function as an epigenetic insulator or coordinate long-range interactions between gene pro-
moters and distant enhancers [15,16]. Notably, mutation of the CTCF binding site within the
E2 ORF of HPV18 resulted in increased production of E6/E7 encoding transcripts, leading to
hyperproliferation of viral genome–containing keratinocytes in organotypic raft culture [13].
CTCF also binds to the DNA genomes of much larger herpesviruses such as Epstein-Barr virus
(EBV), Kaposi sarcoma–associated herpesvirus (KSHV), and herpes simplex virus (HSV-1),
and CTCF recruitment in these viruses is important in the regulation of epigenetic silencing of
latency-associated genes [17–22]. This regulation is in part brought about by the ability of
CTCF to coordinate long-range chromosomal interactions within the viral episomes [19,23].
However, in other contexts, CTCF functions to insulate epigenetic boundaries in these large
DNA viruses [18,24].
The mechanism by which CTCF regulates HPV oncogene expression is not known. In this
study, we identify CTCF- and YY1-dependent loop formation in the HPV18 genome as the
mechanism through which viral oncogene expression is restricted in the early stages of infec-
tion in undifferentiated keratinocytes. We show that down-regulation of YY1 following differ-
entiation results in loss of loop formation and reversal of epigenetic silencing and facilitates
increased oncogene expression and completion of the viral life cycle.
Results
HPV18 induces increased CTCF protein expression in undifferentiated
keratinocytes
To analyse the function of CTCF in the life cycle of HPV18, primary human keratinocytes, the
natural host cell of HPV, were transfected with religated HPV18 genomes, and replicating epi-
somes were established that were stably maintained at approximately 50 copies per cell. We
previously showed that mutation of the CTCF binding site within the E2 ORF of HPV18
(HPV18 ΔCTCF) results in a marked reduction of CTCF binding at this site with no effect on
the establishment of HPV18 episomes in primary keratinocytes [13]. However, the long-term
persistence of herpesvirus saimiri (HVS) has been shown to be dependent on CTCF [25].
Therefore, we serially passaged HPV18 wild-type (WT)- and ΔCTCF-genome–containing
human foreskin keratinocytes (HFKs) and performed Southern blot analysis to examine
HPV18 episome copy-number variation over time. The genome copy number at all passages
analysed (9–11) was similar between HPV18 WT and ΔCTCF genomes, demonstrating that
CTCF binding within the E2 ORF does not play a role in the persistence of HPV18 episomes
(Fig 1A). It is important to note that all of the experiments included in this study were per-
formed on cells between passages 9 and 11 to ensure consistent episomal copy number
between HPV18 WT and ΔCTCF cultures since viral episomes can integrate into the host
genome in long-term culture [26].
To determine whether HPV18 genome establishment alters CTCF protein expression,
we quantified CTCF protein in isogenic primary HFKs. We observed a >2.5-fold increase
in CTCF protein expression following establishment of HPV18 episomes (Fig 1B). This was
consistent in two independent donors and is in agreement with a previous study that dem-
onstrated an increase in CTCF protein expression in HPV31-positive neoplastic cervical
keratinocytes compared to HFKs [27]. Interestingly, the HPV18-induced increase in CTCF
protein is post-transcriptional since quantitative RNA-Sequencing (RNA-Seq) and quanti-
tative reverse transcriptase-PCR (qRT-PCR) analysis of CTCF transcripts did not show any
significant differences in CTCF transcript levels following establishment of HPV18 epi-
somes (Fig 1C and 1D and S1 Table).
Differentiation-dependent regulation of the HPV epigenome
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CTCF binding within the E2 ORF represses E6/E7 transcript production
To determine whether abrogation of CTCF binding at the E2 ORF affects CTCF recruitment
elsewhere in the viral episome, we performed chromatin immunoprecipitation followed by
quantitative PCR (ChIP-qPCR) to specifically amplify CTCF-bound regions throughout the
HPV18 genome (Fig 1E). CTCF binding was enriched at the previously identified E2 ORF
binding site in cells containing HPV18 WT genomes. In addition, CTCF-enriched regions
were identified within the viral LCR, close to the late promoter, and within the L2 ORF. Inter-
estingly, abrogation of CTCF binding at the E2 ORF by mutation resulted in an almost com-
plete loss of CTCF recruitment to all regions of the viral genome, suggesting that CTCF
binding at the E2 ORF influences recruitment to regulatory regions that do not contain CTCF
binding sites. This phenomenon was consistent in both keratinocyte donors tested.
We previously concluded that CTCF recruitment is important in the regulation of HPV18
oncogene expression in differentiated epithelia [13]. Consistent with these results, we found
that in undifferentiated cells, transcripts originating from the early promoter were increased in
abundance in quantitative RNA-Seq experiments (Fig 1F and S2 Table), which was confirmed
by qRT-PCR (Fig 1G). Importantly, our RNA-Seq analysis showed that this increase in early
transcripts is specific to E6/E7 encoding spliced transcripts and not to alternatively spliced E2
encoding mRNA species (Fig 1F and S2 Table), which is in agreement with our previous obser-
vation that E2 protein expression is not altered in HPV18 ΔCTCF genomes compared to WT
[13]. E6 and E7 protein translated from the polycistronic message increased 11.3- and 1.9-fold,
respectively, when the CTCF site was mutated (Fig 1H). To exclude the possibility that abro-
gation of CTCF binding by mutation of the E2–CTCF binding site results in increased E6/E7
transcription by inadvertently affecting the binding of other factors involved in an alternative
regulatory network, CTCF protein levels were depleted by doxycycline-induced expression of
two independent CTCF-specific shRNA molecules in HPV18 WT-genome–containing cells
(Fig 1I). qRT-PCR analysis of E6/E7 encoding transcript levels demonstrated that partial
depletion of CTCF protein resulted in a significant increase in E6/E7 encoding transcripts (Fig
1J). This increase in E6/E7 transcripts was not observed following induction of a nontargeting
shRNA control (Fig 1J).
Fig 1. HPV18 recruits CTCF to regulate E6/E7 transcription. Primary HFKs were transfected with HPV18 WT or ΔCTCF genomes and
episomes established. (A) HPV18 WT and ΔCTCF HFKs were harvested between passages 9 and 11. DNA was digested with DpnI and either
EcoRI to linearise (L) episomes or BglII to digest cellular DNA only. The position of multimeric/integrated (M/I), open circle (OC), and
supercoiled (S) viral genomes are indicated in addition to copy-number loading controls (50 and 100 copies/cell). The average number of viral
episomes per cell was determined in three independent experiments and indicated below the representative blot. (B) CTCF protein levels in
isogenic HPV18-negative and positive HFKs were assessed by western blotting. CTCF protein was quantified by densitometry and normalised to
GAPDH and fold change indicated below. (C) CTCF mRNA levels were determined by quantitative RNA-Seq analysis. Image shows the CTCF
locus (dotted line indicates a large intronic region truncated in the figure). Data are shown as 0–1,400 counts for each track. Quantification of
reads per million counts at the indicated exons (arrows) are shown in S1 Table. (D) qRT-PCR quantification of CTCF mRNA using primers that
amplify the exon 5/6 junction, normalised to β-actin. Data are shown as mean ± SD. (E) CTCF association with the HPV18 genome was
determined by ChIP-qPCR in HPV18 WT and ΔCTCF HFKs and fold enrichment of viral DNA with CTCF-specific antibody calculated in
comparison to nonspecific FLAG antibody. Data are shown as mean ± SD. (F) HPV18 transcripts were analysed by quantitative RNA-Seq. Image
shows the HPV18 ORFs and data plotted as 0–43,500 counts for each track. Quantification of reads per million counts at the indicated loci
(arrows) are shown in S2 Table. (G) qRT-PCR quantification of E6 encoding mRNA using primers that anneal upstream of the E6 splice donor
site (nt 131–180) normalised to β-actin. Data are shown as mean ± SD. (H) E6 and E7 protein levels in HPV18 WT- and ΔCTCF-genome–
containing HFKs were assessed by western blotting. (I) CTCF protein depletion by doxycycline-induced (+) shRNA expression. Fold reduction
compared to uninduced cells (–) is indicated. CNT shRNA is also shown. (J) E6/E7 transcript levels were quantified by qRT-PCR following
depletion of CTCF, normalised to β-actin, and shown as fold change over levels in the absence of doxycycline (2-ΔΔCT). Data are represented as
mean ± SD (���p< 0.001). All raw quantitative data are enclosed in S1 Data. ChIP-qPCR, chromatin immunoprecipitation followed by
quantitative PCR; CNT, nontargeting control; CTCF, CCCTC-binding factor; E, early promoter; GAPDH, Glyceraldehyde-3-phosphate
dehydrogenase; HFK, human foreskin keratinocyte; HPV, human papillomavirus; IgG, immunoglobulin G; L, linear; M/I, multimeric/
integrated; nt, nucleotide; OC, open circle; ORF, open reading frame; qRT-PCR, quantitative reverse transcriptase-PCR; RNA-Seq,
RNA-Sequencing; S, supercoiled; shRNA, short hairpin RNA; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2005752.g001
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CTCF reduces chromatin accessibility and epigenetically represses the
HPV18 LCR
Our data show that recruitment of CTCF within the E2 ORF represses HPV18 early gene
expression, and we hypothesised that this was due to repression of early promoter activity.
Regulatory genomic elements are depleted of nucleosomes, and the remaining nucleosomes
are enriched in active chromatin marks (e.g., acetylated lysine residues in histone H3 and H4)
[28]. Formaldehyde-assisted isolation of regulatory elements (FAIRE) can be used to identify
open and nucleosome-depleted enhancer regions of DNA [29]. To gain mechanistic insight
into the control of HPV early promoter activity by distal CTCF binding, the chromatin accessi-
bility of HPV18 episomes was analysed by FAIRE. We consistently observed a higher FAIRE-
to-input amplification ratio, indicative of open chromatin at the HPV18 WT viral enhancer
and early promoter (Fig 2A). Notably, there was a significant enrichment of open chromatin at
the early promoter of HPV18 ΔCTCF genomes (Fig 2A; p< 0.001). This increased chromatin
accessibility was consistent between independent donor lines and suggests a mechanism by
which CTCF binding at the distal E2 binding site influences nucleosome occupancy within the
viral LCR.
Interestingly, we observed that immediately downstream of the open chromatin area in the
HPV18 WT genome is a region of closed chromatin in the E6 and E7 ORFs and the late pro-
moter, P811. These findings are in agreement with previous DNase I footprinting experiments
that demonstrated dynamic nucleosome binding in the viral enhancer and tightly held nucleo-
somes at the viral late promoter [11]. FAIRE analysis of the HPV18 episome also revealed an
area of open chromatin within the E1 ORF, the specific function of which remains unknown.
We next investigated whether the increased accessibility of chromatin within the viral
LCR following disruption of CTCF binding was associated with any change in active and
repressive epigenetic marks. Using ChIP-qPCR, we analysed levels of the active-promoter–
associated H3K4Me3 mark and the polycomb repressor complex (PRC)-associated repres-
sive H3K27Me3 mark across the HPV18 genome. These experiments revealed an enrich-
ment of H3K4Me3 in HPV18 ΔCTCF genomes compared to WT, particularly within the
viral enhancer and immediately downstream of the early promoter, indicative of active tran-
scription (Fig 2B). In contrast, enrichment of the repressive H3K27Me3 mark was detected
in the enhancer and early gene region of HPV18 WT genomes. This finding was surprising,
given that expression of E6/E7 has been shown to cause a global reduction in cellular
H3K27Me3 [30]. The enrichment of H3K27Me3 was markedly decreased to almost unde-
tectable levels on HPV18 ΔCTCF genomes (Fig 2C). This epigenetic switching of viral
genomes unable to bind CTCF at the E2 ORF is consistent with increased transcriptional
activity of the viral early promoter in ΔCTCF genomes and explains the observed alterations
in chromatin accessibility identified by FAIRE (Fig 2A).
Since H3K27Me3 has been shown to inhibit recruitment of the general transcription
machinery, we examined RNA Pol II recruitment. Indeed, enrichment of RNA Pol II was
observed at the early promoter and within the early gene region in HPV18 ΔCTCF compared
to WT, consistent with increased transcription levels (Fig 2D).
Alteration of the chromatin structure in the viral LCR alters host-cell
epigenetic modifier recruitment
Numerous host-cell transcriptional regulators have been shown to specifically bind to the HPV
LCR and regulate transcription of viral early genes. To determine whether CTCF influences
recruitment of specific cellular regulators of HPV18 transcription, we analysed enrichment of
transcription factors that regulate early gene transcription using ChIP-PCR. Our analysis
Differentiation-dependent regulation of the HPV epigenome
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Fig 2. CTCF regulates the topology, epigenetic status, and RNA Pol II recruitment to the HPV18 episome. (A)
The accessibility of chromatin was assessed by FAIRE. Data show the mean ± SD of qPCR analysis of amplicons in the
HPV18 genome of FAIRE-extracted samples compared to input. A higher FAIRE extract/input ratio indicates a more
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revealed that mutation of the CTCF binding site resulted in significantly reduced binding of the
YY1 transcription factor at both the 50 and 30 enhancers in the viral LCR and at the early and late
promoter regions (Fig 3A). Since YY1 functions in the sequence-specific recruitment of PRCs
PRC1 and PRC2, and we detected enrichment of the PRC2-associated H3K27Me3 repressive
mark in WT HPV18 genomes, we examined PRC1 and PRC2 binding in the HPV18 genome in
WT- and ΔCTCF-genome–containing cells. We found that the PRC2 subunit embryonic ecto-
derm development (EED) was significantly depleted at the viral enhancer and early promoter in
HPV18 ΔCTCF genomes compared to WT, consistent with the observed loss of H3K27Me3
(Fig 3B). Reinforcement of repressed chromatin is achieved via recruitment of PRC1 to the
H3K27Me3 mark and ubiquitylation of K119 on histone H2A by the PRC1 E3 ubiquitin ligase,
ring finger protein 1B (Ring1B) [31]. Our data demonstrated that Ring1B was associated with
the early promoter in HPV18 WT genomes, but binding was dramatically reduced in ΔCTCF
genomes (Fig 3C). Loss of Ring1B was coincident with an almost complete loss of histone 2A
lysine 119 ubiquitinylation (H2AK119Ub) (Fig 3D). These data indicate that in addition to
reduced PRC2 recruitment, PRC1 recruitment to the viral LCR is significantly reduced in
HPV18 ΔCTCF episomes. Our data are consistent with a model in which the abrogation of
CTCF binding in the E2 ORF results in a loss of YY1 binding to the viral LCR, causing reduced
PRC1 and PRC2 recruitment. This leads to reduced H3K27Me3 and H2AK119Ub deposition,
de-repression of the HPV18 early promoter, and the up-regulation of viral oncogene expression.
Epigenetic regulation of HPV18 early gene transcription is mediated by
CTCF-YY1–dependent loop formation
Studies have shown that CTCF and YY1 are able to directly interact and that the assembly of
this protein complex induces chromatin loop formation between distant loci [32,33]. We
therefore hypothesised that the repressive effects of CTCF binding in the E2 ORF is mediated
through loop formation between the YY1-bound viral enhancer and the downstream CTCF-
bound E2 ORF. To test this hypothesis, we used chromosome conformation capture (3C), a
method that can be used to directly measure inter- and intramolecular interactions between
specific distal loci. HPV18 WT and ΔCTCF genomes were cross-linked in situ, and chromatin
was extracted and digested with the NlaIII restriction enzyme, which restricts the viral DNA at
multiple sites (Fig 4A). Digestion efficiency was determined for each sample by qPCR analysis
of amplicons that are sensitive to digestion compared with a PCR amplicon that is insensitive
to digestion. Samples were only processed further if the digestion efficiency was above 90%.
Proximity ligation at low dilution was then carried out to ligate restriction fragments contain-
ing DNA loci that are physically associated through interactions between chromatin-bound
factors. We designed unidirectional PCR primers to amplify a 346 bp amplicon across the liga-
tion junction that would be formed if the restriction fragments containing the CTCF site in
the E2 ORF and the LCR were ligated together as a result of the formation of a chromatin loop
(Fig 4A and 4B).
open chromatin structure (���p< 0.001). Enrichment of H3K4Me3 (B), H3K27Me3 (C), and RNA Pol II (D) was
assessed by ChIP-qPCR. Data show qPCR analysis of ChIP as fold binding over IgG (FLAG antibody) and are
represented as mean ± SD. The inset western blot images show relative protein expression in HPV18 WT- and
ΔCTCF-genome–containing cells. The linearised HPV18 genome and CTCF–E2 ORF binding site (blue) are indicated
below. All raw quantitative data are enclosed in S1 Data. ChIP-qPCR, chromatin immunoprecipitation followed by
quantitative PCR; CTCF, CCCTC-binding factor; E, early promoter; FAIRE, formaldehyde-assisted isolation of
regulatory elements; GAPDH, Glyceraldehyde-3-phosphate dehydrogenase; H3K4Me3, histone 3 lysine 4
trimethylation; H3K27Me3, histone 3 lysine 27 trimethylation; HPV, human papillomavirus; IgG, immunoglobulin G;
L, late promoter; LCR, long control region; ORF, open reading frame; qPCR, quantitative PCR; RNA Pol II, RNA
polymerase II; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2005752.g002
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3C analysis of HPV18 WT genomes consistently detected a PCR product of the correct size
formed by ligation of the E2 ORF to the LCR. In addition, the 346 bp PCR products were
Fig 3. Abrogation of CTCF binding to the E2 ORF reduces YY1 and polycomb recruitment to the HPV18 episome. YY1
(A), EED (B), Ring1B (C), and H2AK119Ub (D) enrichment were assessed by ChIP-qPCR of amplicons within the HPV18
LCR. Data are represented as mean ± SD. (�p< 0.05, ��p< 0.01, ���p< 0.001). Relative protein expression is shown in the
western blots. The viral LCR, Enh regions, and early and late promoters are indicated. All raw quantitative data are enclosed
in S1 Data. ChIP-qPCR, chromatin immunoprecipitation followed by quantitative PCR; CTCF, CCCTC-binding factor; E,
early promoter; EED, embryonic ectoderm development; Enh, enhancer; GAPDH, Glyceraldehyde-3-phosphate
dehydrogenase; H2AK119Ub, histone 2A lysine 119 ubiquitinylation; HPV, human papillomavirus; L, late promoter; LCR,
long control region; ORF, open reading frame; Ring1B, ring finger protein 1B; WT, wild-type; YY1, Yin Yang 1.
https://doi.org/10.1371/journal.pbio.2005752.g003
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Fig 4. CTCF and YY1 coordinate intrachromosomal interactions within the HPV18 episome between the E2 ORF
and the LCR. (A) Diagram of the HPV episome is depicted in linear form. ORFs, LCR, early (E) and late (L) promoters,
CTCF (blue) and YY1 (aqua) binding sites, NlaIII restriction sites (green arrows), and primer annealing sites (red
arrows) including the E2–ORF anchor primer (�), LCR primer (1), and L2–ORF primer (2). (B) PCR analysis of 3C
products from HPV18 WT- and ΔCTCF-genome–containing cells as indicated by the schematic to the right.
Amplification of serial dilutions (pg) of synthesised predicted ligation products are shown in lanes 1–3, and molecular
weight markers are shown on the left. (C) Densitometric analysis of 3C products in HPV18 WT- and ΔCTCF-genome–
containing cells in two independent keratinocyte donors. Data are the mean ± SEM of at least three independent
experiments. (D) Efficiency of CTCF depletion relative to control is indicated below the image in induced cells (+)
compared to expression in uninduced cells (–). (E) 3C analysis was performed following Dox-induced (+) shRNA
expression in shCNT and shCTCF (1, 2, and 3) transduced HPV18-genome–containing HFKs. The upper panel shows
amplification of E2–LCR ligation product, and the middle panel shows amplification of E2–L2 ligation product. Lower
panel shows E1 ORF amplification. (F) 3C products were analysed by densitometry, and relative intensity of bands in
comparison to uninduced samples was determined. Data are the mean and SEM of at least three independent
experiments. (G) YY1 depletion was assessed by western blotting alongside β-actin as a loading control. Fold depletion
in comparison to uninduced samples is indicated below the blots. (H) 3C analysis of E2–LCR interactions following
shRNA-mediated depletion of YY1. E2–LCR interactions are shown in the top panel in uninduced (–) and induced (+)
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excised from the gel and sequenced to confirm ligation between the YY1-bound viral LCR and
CTCF-bound E2 ORF (S1 Fig). Given the small size of the HPV genome, we controlled for
nonspecific interactions by carrying out PCR using primers designed to amplify ligation prod-
ucts between the CTCF-bound E2 ORF and the L2 ORF. No interactions were detected
between these regions of the genome, although the E2–L2 primers efficiently amplified synthe-
sised DNA molecules containing this ligation junction (Fig 4B, middle panel). We also per-
formed a PCR reaction with primers that anneal within the E1 ORF that are insensitive to
NlaIII digestion to ensure equal amplification of digested input chromatin in all 3C experi-
ments (Fig 4B, lower panel). Notably, we found that looping between the YY1-bound LCR and
the E2 ORF was significantly reduced in HPV18 ΔCTCF genomes in both donor lines tested
(Fig 4C). To confirm that the reduction in E2 ORF–LCR interactions in HPV18 ΔCTCF was
due to abrogation of CTCF binding, CTCF protein levels were depleted in HPV18-genome–
containing keratinocytes using three independent shRNA lentiviral vectors following induc-
tion of shRNA expression with doxycycline (Fig 4D). While E2–LCR interactions were consis-
tently detected in control shRNA-expressing cells, this interaction was significantly reduced
following partial depletion of CTCF with all three independent shRNA molecules (Fig 4E and
4F). These data therefore demonstrate that CTCF directs the formation of a chromatin loop
between the viral LCR and E2 ORF.
We next assessed the role of YY1 in the formation of this chromatin loop by shRNA-medi-
ated depletion of YY1. HPV18-genome–containing cells were transduced with lentivirus
expressing doxycycline-inducible YY1-specific shRNA (Fig 4G). 3C analysis demonstrated
that depletion of YY1 resulted in a consistent and significant reduction in E2–LCR interactions
(Fig 4H and 4I). Together, our data demonstrate that E2–LCR loop formation in the HPV18
genome requires both CTCF and YY1.
To confirm that YY1-CTCF–dependent chromatin loop formation within the HPV18 epi-
some regulates chromatin topology, we used FAIRE to assess the chromatin structure within
the viral LCR and flanking regions following shRNA-mediated depletion of CTCF (Fig 5A)
and YY1 (Fig 5B). These experiments revealed a significant increase in chromatin accessibility
within the LCR following depletion of either CTCF or YY1, consistent with the increase in
chromatin accessibility in HPV18 ΔCTCF genomes that are unable to bind CTCF.
Our data show that CTCF and YY1 contribute to chromatin loop formation within the
HPV18 genome, resulting in epigenetic repression of early gene expression. To determine
whether CTCF and YY1 binding to the viral genome are interdependent, we depleted CTCF
protein by shRNA induction and performed ChIP for CTCF and YY1 at the viral LCR and
E2–CTCF binding site (Fig 5C). Depletion of CTCF protein resulted in reduced recruitment
of CTCF to the E2–CTCF binding site and also a reduction in binding in the viral LCR. Nota-
bly, CTCF depletion also resulted in reduced YY1 recruitment to the LCR, and YY1 depletion
resulted in reduced CTCF binding at the E2–CTCF binding site (Fig 5D). These data suggest
that CTCF binding at the E2 ORF stabilises YY1 binding at the LCR and vice versa and that
the enrichment of these proteins within the viral genome is interdependent.
HPV18-genome–containing HFKs transduced with shCNT and shYY1 lentivirus. E2–L2 interactions are shown in the
bottom panel. (I) 3C products were analysed by densitometry, and relative intensity of bands in comparison to
uninduced samples was determined. Data are the mean and SEM of six independent experiments. �p< 0.05, ��p< 0.01,
���p< 0.001 in all experiments. All raw quantitative data are enclosed in S1 Data. CNT, nontargeting control; CTCF,
CCCTC-binding factor; Dox, doxycycline; E, early promoter; HFK, human foreskin keratinocyte; HPV, human
papillomavirus; L, late promoter; LCR, long control region; ORF, open reading frame; SEM, standard error of the mean;
shRNA, short hairpin RNA; WT, wild-type; YY1, Yin Yang 1; 3C, chromosome conformation capture.
https://doi.org/10.1371/journal.pbio.2005752.g004
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It has previously been shown using transcriptional reporter plasmids that YY1 plays a piv-
otal role in the repression of HPV enhancer activity [7,8]. To confirm that YY1 is an essential
repressor of HPV18 early gene expression in the context of the HPV genome, YY1 protein was
depleted by YY1-specific shRNA expression as previously described and E6/E7 encoding viral
transcripts quantified by qRT-PCR. Depletion of YY1 resulted in an over 20-fold increase in
E6/E7 transcript levels (Fig 6A), confirming the role of YY1 as a transcriptional repressor in
the HPV life cycle.
HPV gene expression during the virus life cycle is dependent on keratinocyte differentia-
tion. Differentiation of infected keratinocytes in the midlayers of epithelia corresponds to an
increase in early promoter activity [34–37]. In agreement with these studies, synchronous dif-
ferentiation of keratinocytes by suspension of keratinocytes in semisolid medium for 48 hr
resulted in a 2.6-fold increase in E6/E7 encoding transcripts in both keratinocyte donors (Fig
6B) and protein expression of the intermediate–early keratinocyte differentiation marker invo-
lucrin and a marker of the productive phase of the HPV life cycle, E1^E4 (Fig 6C). It has previ-
ously been shown that CTCF protein is localised to the nucleus of human keratinocytes and
that expression is reduced in differentiated layers of human skin [38] and following morpho-
logical differentiation of human corneal epithelial cells [39]. Because of the known interaction
between CTCF and YY1 and the functional role of this interaction in 3D chromatin loop for-
mation, we also analysed YY1 expression in HPV18-genome–containing keratinocytes grown
in monolayer (undifferentiated) or synchronously differentiated by suspension in methylcellu-
lose for 48 hr. Western blot analysis of lysates of undifferentiated and differentiated cells
revealed no difference in CTCF protein expression (Fig 6C), and importantly, CTCF protein
was expressed at similar levels in HPV18 WT- and ΔCTCF-genome–containing cells (expres-
sion in HPV18 ΔCTCF compared to WT was 0.94-fold ± 0.18 SD; p = 0.97). However, a signif-
icant reduction of YY1 protein expression was observed in both HPV18 WT- and ΔCTCF-
genome–containing cultures (Fig 6C and 6D), and this was consistent in two independent ker-
atinocyte donors.
Since keratinocyte differentiation results in a marked reduction in YY1 protein expression,
we examined whether cellular differentiation results in reduced CTCF and YY1 recruitment to
the HPV18 genome. HPV18 WT-genome–containing cells were differentiated in methylcellu-
lose and CTCF, and YY1 recruitment was analysed by ChIP. Differentiation of the cells
resulted in reduced CTCF recruitment throughout the viral genome (Fig 6E) and a dramatic
and complete loss of YY1 recruitment to the viral LCR (Fig 6F). To determine the effect of the
differentiation-induced reduction in YY1 expression and recruitment to the HPV18 genome
on the interaction between the E2–CTCF binding site and the viral LCR, 3C analysis was car-
ried out using undifferentiated HPV18 WT-genome–containing cells harvested after growth
in monolayer culture or genome-containing cells differentiated through incubation in
Fig 5. Depletion of CTCF or YY1 results in increased chromatin accessibility within the HPV18 LCR. Chromatin
topology was assessed by FAIRE as previously described. Depletion of CTCF (A; shCTCF1 and shCTCF2) and YY1 (B;
shYY1) protein in WT HPV18 genome containing cells is shown in the inset panels in comparison to shCNT. Data
show mean ± SD of qPCR analysis of FAIRE-extracted samples of representative experiments performed in triplicate.
Each experiment was performed at least three times with similar results. (C) Recruitment of CTCF (upper panel) and
YY1 (lower panel) to the viral LCR and E2–CTCF binding site following Dox induction of shCTCF was assessed by
ChIP-qPCR, and (D) recruitment of CTCF to the E2 ORF following shYY1 induction was assessed by ChIP-qPCR.
Data show mean ± SD. ���p< 0.001, ��p< 0.01, �p< 0.05 in all experiments. All raw quantitative data are enclosed in
S1 Data. ChIP-qPCR, chromatin immunoprecipitation followed by quantitative PCR; CTCF, CCCTC-binding factor;
Dox, doxycycline; E, early promoter; Enh, enhancer; FAIRE, formaldehyde-assisted isolation of regulatory elements;
HPV, human papillomavirus; IgG, immunoglobulin G; L, late promoter; LCR, long control region; ORF, open reading
frame; qPCR, quantitative PCR; shCNT, nontargeting shRNA control; shRNA, short hairpin RNA; WT, wild-type;
YY1, Yin Yang 1.
https://doi.org/10.1371/journal.pbio.2005752.g005
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Fig 6. Host cell differentiation controls E2–LCR intrachromosomal interactions through repression of YY1
protein expression. (A) Fold expression change of E6/E7 encoding transcripts was determined by qRT-PCR following
shYY1 normalised to β-actin and compared to shCNT. Data show mean ± SEM of three independent experiments
Differentiation-dependent regulation of the HPV epigenome
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methylcellulose for 48 hrs. We found that E2–LCR interactions were significantly reduced fol-
lowing cellular differentiation in two independent keratinocyte donors (Fig 6G and 6H).
Host cell differentiation results in epigenetic de-repression of HPV18
chromatin and increased LCR accessibility
We next tested whether the decreased looping between the E2 ORF and the LCR we observed
on keratinocyte differentiation resulted in changes in the epigenetic status and chromatin
accessibility of HPV18 WT genomes. ChIP-qPCR analysis of H3K4Me3 and H3K27Me3 levels
revealed enrichment of the active H3K4Me3 mark and loss of H3K27Me3 modifications,
indicative of transcriptional de-repression following differentiation (Fig 7A). In contrast, dif-
ferentiation of ΔCTCF HPV18-genome–containing cells that we previously showed were in
enriched H3K4Me3 histone marks when undifferentiated (Fig 2B) did not result in any further
enrichment of H3K4Me3 following differentiation, indicating aberrant regulation of epige-
netic changes upon cellular differentiation in genomes unable to recruit CTCF (Fig 7B). We
next examined whether this switching of epigenetic modifications results in increased accessi-
bility of the chromatin using FAIRE. Our data demonstrated that differentiation of HPV18-ge-
nome–containing cells resulted in significant depletion of nucleosomes in the HPV18 LCR
(Fig 7C). Taken together, our data demonstrate that upon cellular differentiation, reduced
YY1 protein expression and recruitment to the viral LCR leads to the loss of chromatin loop
formation, depletion of repressive epigenetic marks, and an associated increase in LCR chro-
matin accessibility. These observations therefore elucidate the mechanism underlying the pro-
gressive up-regulation of HPV18 E6 and E7 expression during keratinocyte differentiation, a
mechanism likely to play a critical role in the successful completion of the viral life cycle.
Discussion
CTCF is a major regulator of host and virus transcription and mediates many of its functions
by the coordination of dynamic long-range chromosomal interactions [15]. In this study, we
show that mutation of the CTCF binding site with the E2 ORF of HPV18 results in a signifi-
cant depletion of CTCF binding throughout the HPV genome. This interesting phenomenon
suggested that intramolecular interactions occur between distinct regions of the HPV18 epi-
some and that these interactions are stabilised by CTCF bound at the E2 ORF. For example,
CTCF association with LCR-specific sequences, devoid of CTCF consensus binding sites [13],
performed in triplicate. (B) Fold expression of E6/E7 encoding transcripts after methylcellulose-induced keratinocyte
differentiation was determined by qRT-PCR. Data show mean ± SEM in two keratinocyte donors normalised to β-
actin and compared to undifferentiated cells. (C) YY1 protein expression in undifferentiated and differentiated HPV18
WT and ΔCTCF HFKs was assessed by western blotting. Involucrin and HPV18 E1^E4 expression was analysed as
markers of differentiation. (D) YY1 protein expression was quantified and normalised to GAPDH. Data show
normalised YY1 expression relative to undifferentiated cells in four independent experiments ± SEM. CTCF (E) and
YY1 (F) recruitment in undifferentiated and differentiated cells were assessed by ChIP-qPCR. Data are represented as
mean ± SD. (G) E2–LCR interactions were determined by 3C analysis in undifferentiated and differentiated
keratinocytes. The top panel shows amplification of E2–LCR ligation products, and the middle panel shows
amplification of E2–L2 ligation products. Lower panel shows E1 ORF amplification. (H) E2–LCR interactions in
HPV18 WT genomes were quantified in multiple experimental repeats in each of two independent donors following
cellular differentiation. Data are shown as mean ± SEM. ��p< 0.01, ���p< 0.001 in all experiments. All raw
quantitative data are enclosed in S1 Data. ChIP-qPCR, chromatin immunoprecipitation followed by quantitative PCR;
CTCF, CCCTC-binding factor; D, differentiated; E, early promoter; GAPDH, Glyceraldehyde-3-phosphate
dehydrogenase; HFK, human foreskin keratinocyte; HPV, human papillomavirus; IgG, immunoglobulin G; L, late
promoter; LCR, long control region; ORF, open reading frame; qRT-PCR, quantitative reverse transcriptase PCR;
SEM, standard error of the mean; shCNT, nontargeting shRNA control; shRNA, short hairpin RNA; shYY1, shRNA
depletion of YY1; U, undifferentiated; WT, wild-type; YY1, Yin Yang 1; 3C, chromosome conformation capture.
https://doi.org/10.1371/journal.pbio.2005752.g006
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could occur via indirect interaction with the CTCF-bound E2 ORF, suggesting that the viral
genome is organised by distinct intramolecular interactions. The global reduction of CTCF
binding, by either mutation of the E2 binding site or by induction of CTCF-specific shRNA,
resulted in increased E6/E7 transcript and protein production. We therefore hypothesised that
CTCF mediates intrachromosomal interactions that are important for controlling the activity
of the viral early promoter (depicted in Fig 8).
Analysis of the epigenetic status of the HPV18 WT episome revealed several important fea-
tures. H3K4Me3 enrichment, indicative of active promoter regions, was observed at the early
Fig 7. Host cell differentiation induces epigenetic switching and enhancer accessibility in HPV18 episomes. (A) Enrichment of
H3K4Me3 (upper panel) and H3K27Me3 (lower panel) epigenetic marks was assessed in HPV18 episomes in undifferentiated (blue) and
methylcellulose-differentiated (green) cells. Data show qPCR analysis at defined regions in the HPV18 genome as fold binding over IgG.
The inset western blots show relative protein expression. (B) Enrichment of H3K4Me3 was assessed in ΔCTCF HPV18 episomes in
undifferentiated (red) and methylcellulose-differentiated (purple) cells. The inset western blots show relative protein expression. (C)
Chromatin accessibility following host cell differentiation was assessed by FAIRE. Data show qPCR analysis of amplicons in the HPV18
genome of FAIRE-extracted samples compared to Input in undifferentiated and differentiated HPV18 WT HFKs. The linearised HPV18
genome and CTCF–E2 ORF binding site are indicated. Data are represented as mean ± SD. (���p< 0.001). All raw quantitative data are
enclosed in S1 Data. CTCF, CCCTC-binding factor; E, early promoter; FAIRE, formaldehyde-assisted isolation of regulatory elements;
H3K4Me3, histone 3 lysine 4 trimethylation; H3K27Me3, histone 4 lysine 27 trimethylation; HPV, human papillomavirus; IgG,
immunoglobulin G; L, late promoter; LCR, long control region; ORF, open reading frame; qPCR, quantitative PCR; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2005752.g007
Fig 8. Model of differentiation-dependent looping and epigenetic control of HPV oncogene transcription. The HPV
life cycle is dependent on infection of differentiating epithelia. Infection is established in the undifferentiated basal cells, in
which a tightly controlled programme of viral gene expression is initiated. Expression of viral early genes (E6, E7) is
attenuated in undifferentiated cells by the establishment of a CTCF-YY1–dependent chromatin loop of epigenetically
repressed chromatin. As cells begin the programme of terminal differentiation, increased E6/E7 expression is required to
maintain the cell in a proliferative state. This is coordinated by a differentiation-induced reduction in YY1 protein
expression, which releases the repressive chromatin loop and attenuates PRC complex recruitment and loss of H3K27Me3
deposition. Increased accessibility and reduced H3K27Me3 at the viral enhancer results in de-repression of the early
promoter, increased RNA Pol II recruitment, and H3K4Me3 deposition, resulting in increased E6/E7 oncogene expression.
CTCF, CCCTC-binding factor; H3K4Me3, histone 3 lysine 4 trimethylation; H3K27Me3, histone 3 lysine 27 trimethylation;
HPV, human papillomavirus; PRC, polycomb repressor complex; RNA Pol II, RNA polymerase II; YY1, Yin Yang 1.
https://doi.org/10.1371/journal.pbio.2005752.g008
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and late promoter regions in comparison to other regions in the HPV18 genome. In contrast,
repressive H3K27Me3 levels were low at the early promoter, consistent with a previous study in
HPV31 [10]. However, higher levels of H3K27Me3 were observed in the viral LCR, suggesting
epigenetic repression of enhancer activity in undifferentiated cells, which has not previously
been shown. Enhanced enrichment of H3K27Me3 was also observed at the late promoter.
Quantitative analysis of these epigenetic marks in HPV18 ΔCTCF episomes demonstrated that
attenuation of CTCF binding resulted in dramatic epigenetic switching in the viral genome, as
evidenced by increased accessibility of the viral enhancer within the LCR and an enrichment of
H3K4Me3 alongside a global loss of H3K27Me3 marks. This alteration in chromatin accessibil-
ity and epigenetic status correlated with enhanced recruitment of RNA Pol II. We previously
reported that mutation of the CTCF binding within the E2 ORF of HPV18 results in a reduction
in exon 416 to 929 inclusion [13]. Cotranscriptional splicing of RNA is physically linked to
RNA Pol II activity, and it has been clearly demonstrated that transcription elongation dynam-
ics influence intron identification and processing by the spliceosome (reviewed by [40]). We
therefore hypothesise that the observed alteration of HPV transcript splicing [13] is due to
altered RNA Pol II dynamics, and we will formally test this hypothesis in future studies.
YY1 in part functions as a cellular transcriptional repressor by mediating the recruitment of
PRC1 and PRC2 to specific enhancer loci [41,42]. PRC2 catalyses H3K27Me3 deposition while
PRC1 catalyses H2AK119Ub deposition, together resulting in transcriptional repression. Since
a dramatic loss of H3K27Me3 enrichment was observed in HPV18 genomes unable to bind
CTCF, we hypothesised that PRC2 was depleted. We demonstrated significant loss of the
PRC2 component EED, providing evidence that PRC2 recruitment is reduced in HPV18
ΔCTCF genomes, resulting in reduced H3K27Me3 deposition. In addition, a significant reduc-
tion of the PRC1 catalytic subunit Ring1B to the viral early promoter was observed, resulting
in reduced H2AK119Ub deposition. The reduction in both PRC1 and PRC2 recruitment to
the viral LCR following abrogation of CTCF binding explains the loss of repressive epigenetic
marks and increased chromatin accessibility and activity of the P105 early promoter.
CTCF and YY1 can physically associate to stabilise chromatin loops, and organisation of
the host cell genome in this manner controls specific gene-expression switching in X chromo-
some inactivation and neural cell differentiation [32,33]. Combined with our data showing the
global loss of CTCF recruitment within the HPV18 genome when the dominant E2 ORF bind-
ing site was mutated and CTCF-mediated regulation of LCR topology and YY1 enrichment,
we hypothesised that CTCF and YY1 mediate an intramolecular interaction between the E2
ORF and the LCR to stabilise an epigenetically repressed chromatin domain. We demon-
strated a specific interaction between the E2 ORF and LCR that was dependent on CTCF and
YY1 expression. We show that disruption of the E2–LCR interaction results in transcriptional
de-repression of the viral early promoter through a dramatic alteration of the epigenetic status
of the viral episome and increased chromatin accessibility. Such short-range interactions have
been previously identified in cellular loci using similar methods, including interactions
between the insulin gene promoter and distal enhancer and within the 2.5 kbp CD68 gene
[43,44]. In addition, a recent study has demonstrated genomic interactions within the KSHV
genome, ranging from 5 kbp to>80 kbp in size [45]. These studies provide evidence that
short-range genomic loci are important in the regulation of host cell and episomal virus tran-
scription regulation. However, it is important to note that the 3C analysis used in our studies
could also detect interchromosomal interactions between multiple viral episomes in the same
cell. Such interactions between viral episomes could stabilise the formation of viral super
enhancers [46] and/or function in the homologous recombination-dependent replication of
episomes in replication centres [47].
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Our results provide important insight into YY1 and CTCF function in transcriptional con-
trol. We demonstrate that depletion of CTCF reduces YY1 recruitment and vice versa, suggest-
ing that CTCF and YY1 bind to the viral genome in a cooperative manner. CTCF and YY1
have been shown to physically interact [33], and studies have shown that YY1 and CTCF can
anchor loops via homo- and heterodimerisation [32,48]. It has previously been shown that
over 30% of YY1-occupied sites in the human genome are at locations directly adjacent to
CTCF-occupied sites, but that the binding of these factors do not directly colocalise, suggesting
that these factors work together to cooperatively influence occupancy at adjacent binding sites
[32, 49]. YY1 is enriched at sites within the host chromatin that engage in 3D looping, and
YY1 enrichment at these sites is reduced when these elements are not connected, suggesting
that YY1 binding is stabilised by 3D chromatin interactions [32]. It has therefore been sug-
gested that CTCF binding initially serves as an architectural ‘seed’ and that YY1 binding then
connects CTCF-bound nearby regulated genes and enhancers. Our results show that depletion
of CTCF reduces YY1 recruitment, consistent with this hypothesis, but also suggest that CTCF
binding is also influenced by YY1 recruitment.
In the HPV life cycle, the E6 and E7 oncoproteins are expressed at low levels in basal kerati-
nocytes, presumably to limit host immune activation and because their combined functions in
the cell cycle to maintain expression of the cellular DNA replication machinery are less impor-
tant in these undifferentiated, cycling cells. Host cell differentiation is associated with increased
viral early transcript production, resulting in increased E6/E7 protein expression as well as acti-
vation of the late promoter [35]. E6 and E7 act to maintain host cell proliferation, maintaining
viral access to the host cell DNA replication machinery, and it has been shown that viral genome
amplification in differentiated epithelia requires robust E6 expression [50]. Our data demon-
strated a significant reduction in E2–LCR loop formation in differentiated keratinocytes and an
associated reduction in epigenetic repression of the viral genome and increased accessibility of
the LCR. Our results support a model in which the level of YY1 protein expression controls
viral oncogene expression during differentiation.
The in-depth analysis of the epigenetic status and topology of HPV18 episomes in a physio-
logical model of the HPV18 life cycle has provided mechanistic insight into the underlying dif-
ferentiation-dependent control of HPV18 early gene expression. We have demonstrated that
CTCF and YY1 together function in coordinating a transcriptional switch that is directly
linked to host cell differentiation (Fig 8). This ensures low-level expression of viral proteins in
the basal cells, which presumably facilitates persistence in vivo. As infected cells differentiate,
the epigenetically repressed chromatin loop responsible for attenuating activity of the viral
enhancer is disrupted, and the repressive epigenetic marks are lost. We show that this mecha-
nism of controlling viral gene expression is regulated by CTCF-YY1 interactions within the
HPV18 episome; as cells differentiate, YY1 protein expression is repressed and loop formation
is disrupted, promoting enhancer activation.
Whether this mechanism of differentiation-dependent regulation of HPV oncogene expres-
sion plays a role in HPV-driven cancer is not clear, but it is tempting to speculate that this is
the case. YY1 binding sites are often mutated in the HPV16 genome in cervical cancer [51,52],
and a recent study has demonstrated that an open chromatin state of the viral LCR correlates
with high E6/E7 expression in a model of HPV16-driven carcinogenesis [12]. Since the CTCF
binding site within the E2 ORF is conserved in HPV16 [13], we predict that a similar mecha-
nism of oncogene repression exists in HPV16. In addition, CTCF recruitment to the E2 ORF
within integrated HPV18 DNA in HeLa cells is very low even though the CTCF binding site is
intact [53]. Low CTCF binding in HeLa cells is coincident with low H3K27Me3 and high
H3K4Me3 marks at the viral LCR and early promoter, combined with high E6/E7 transcript
production, which is in agreement with our findings in HPV18 ΔCTCF episomes. It will
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therefore be of importance to determine whether CTCF-mediated attenuation of viral onco-
gene expression is disrupted in HPV-driven cancers. To begin to answer this question, we
have analysed CTCF binding-site mutations in a cohort of 3,215 HPV16 positive lesions and
correlated our findings with clinical outcome [54]. A variation in the CTCF binding-site motif
2 was discovered in 357 individual HPV16 sequences (A2938 to G), which we predict would
enhance CTCF binding [55]. Interestingly, the presence of this genetic variation in the HPV16
genome is significantly associated with decreased cancer incidence when compared to the
cases with no variation in the vicinity of the binding site (p = 0.050, one-tailed Fisher’s test).
We therefore speculate that in lesions that contain this variant of HPV16, CTCF may bind
with higher affinity and have a more significant effect on the attenuation of E6/E7 expression,
thereby reducing the risk of cancer development. In addition to genetic variations within the
CTCF binding site, we also found many sequences that had no sequence information at and
around the E2 ORF CTCF binding site. This could be due to integration of the virus such that
the E2 coding sequence is disrupted, but in addition to this widely reported mechanism of
HPV-driven carcinogenesis, it will be important to determine the mechanism and conse-
quence of CTCF exclusion in cancers with integrated HPV DNA.
Materials and methods
Ethics statement
The collection of circumcised foreskin tissue from newborns for the isolation of primary HFKs
for investigation of HPV biology was approved by Southampton and South West Hampshire
Research Ethics Committee A (REC Reference number 06/Q1702/45). Written consent was
obtained from the parent or guardian. The study was approved by the University of Birming-
ham Ethical Review process (ERN_16–0540).
Plasmids and antibodies
pGEMII-HPV18 (gift from F. Stubenrauch, University of Tu¨bingen, Germany) contains the com-
plete HPV18 genome cloned into the EcoRI site of pGEMII and was used to create pGE-
MII-HPV18-ΔCTCF, which contains three conservative nucleotide substitutions (C2993T, G3005A,
T3020C) within the E2 coding region to abolish CTCF binding as previously described [13].
CTCF (61311), H3K4Me3 (39915), H3K27Me3 (39155), RNA Pol II (61081), SP1 (39058),
TEF1 (61644), EZH2 (39901), EED (61203), and Ring1B (39663) and antibodies were pur-
chased from Active Motif (La Hulpe, Belgium). YY1 antibody (SC-7341X) was purchased
from Santa Cruz Biotechnology (Dallas, TX, United States of America). H2AK119Ub (D27C4)
was purchased from Cell Signaling Technology, Inc (Danvers, MA, USA). FLAG M2 was pur-
chased from Sigma-Aldrich (Gillingham, United Kingdom), E7 clone 8E2 (ab100953) was pur-
chased from Abcam (Cambridge, UK), and E6 clone G7 (SC-365089) and Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) antibody were purchased from Santa Cruz Biotechnol-
ogy (Dallas, TX, USA). Monoclonal HPV18 E1^E4 antibody 1D11 was produced by S. Roberts
[56]. All horseradish-peroxidase–conjugated secondary antibodies were purchased from Jack-
son Laboratories (Bar Harbor, ME, USA).
Primary keratinocyte culture, transfection, and organotypic raft culture
The transfection of normal primary HFKs from neonatal foreskin epithelia with recircularised
HPV18 WT and ΔCTCF genomes was performed in S. Roberts’ laboratory by J. Parish as pre-
viously described [13,57]. To eliminate donor-specific effects, primary cells from two foreskin
donors were used: one isolated in house and one commercially available (Lonza, Basel,
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Switzerland). Episome copy number in each cell line was determined by Southern blotting as
described previously [26] and calculated by densitometry of three technical repetitions of each
HPV18-transfected keratinocyte donor compared to the 50 copies per cell loading control.
Digestion of the DNA with EcoRI results in linearisation of episomes, whereas digestion with
BglII restricts the host cell DNA but not the viral DNA to reveal integrated or multimeric
virus. DpnI digests input DNA only.
Organotypic raft cultures were prepared as previously described [13,57,58] and cultured for
14 d in E medium [58] without epidermal growth factor to allow cellular stratification. Rafts
were fixed in 3.7% formaldehyde and paraffin embedded prior to sectioning (Propath Ltd.,
Hereford, UK).
Methylcellulose-induced differentiation of keratinocytes
HPV18-genome–containing keratinocytes (3 × 106 cells) were suspended in E medium con-
taining 10% FBS and 1.5% methylcellulose and incubated at 37˚C, 5% CO2 for 48 h. Cells were
then harvested by centrifugation at 250 × g and then thoroughly washed with ice-cold PBS.
Cells were then either resuspended in medium containing 1% formaldehyde to cross-link for
ChIP and 3C or in urea lysis buffer for protein extraction.
Chromatin immunoprecipitation
ChIP assays were carried out using the ChIP-IT Express kit (Active Motif) following the man-
ufacturer’s instructions. Briefly, cells were fixed in 1% formaldehyde for 3 min at room tem-
perature, quenched in 0.25 M glycine, and washed in ice-cold PBS. Nuclei were released by 40
strokes in a tight dounce homogeniser. Samples were sonicated at 25% amplitude for 30 s on/
30 s off for a total of 15 min using a Sonics Vibracell sonicator fitted with a microprobe. ChIP
efficiency was assessed by quantitative PCR (qPCR) using SensiMix SYBR master mix using an
MXPro 3000 (Agilent Technologies, Santa Clara, CA, USA). Primer sequences for ChIP exper-
iments are shown in Table 1. Cycle threshold (CT) values were calculated at a constant thresh-
old for each experiment, and fold-enrichment–compared to negative control FLAG antibody
was calculated using the following formula:
Fold binding over IgG = (2ΔCT target)/(2ΔCT IgG),
where ΔCT target = Input CT−Target CT and ΔCT IgG = Input CT−IgG CT. Each ChIP
experiment was performed in triplicate, and data shown are the mean ± SD of a representative
experiment. Biological repeats were performed for each experiment a minimum of three times
with similar results.
Western blotting
Cells were lysed in urea lysis buffer (8 M Urea, 100 mM Tris-HCl, pH 7.4, 14 mM β-mercap-
toethanol, protease inhibitors) and protein concentration determined by Bradford assay.
Equal amounts of protein were separated by SDS-PAGE and western blotting carried out
using conventional methods.
RNA-Seq and qRT-PCR
RNA was extracted with an RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s protocol and DNase treated. For RNA-Seq, libraries were prepared using Tru-
Seq Stranded mRNA Library Prep kit for NeoPrep (Illumina, San Diego, CA, USA) using 100
ng total RNA input according to manufacturer’s instructions. Libraries were pooled and run
as 75-cycle–pair end reads on a NextSeq 550 (Illumina) using a high-output flow cell.
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cDNA was synthesised using Superscript III (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s instructions. qPCR was performed using a Stratagene Mx3005P detection
system with SyBr Green incorporation and the primers listed in Table 2.
FAIRE
Cells were fixed and chromatin extracted and sheared as described above for ChIP. FAIRE
analysis was then carried out as previously described [29]. Briefly, two aliquots of chromatin
were taken, each containing chromatin from approximately 2 × 106 cells, one for Input and
one for FAIRE. To the FAIRE samples, 150 μl water was added. To the Input sample, 150 μl
water and 10 μl of 5 M NaCl were added, and the samples were incubated at 95˚C for 15 min
to reverse the crosslinks. RNaseA (10 μg/μl) was added, and the samples incubated at 37˚C for
15 min. Proteinase K (0.5 μg/μl) was added followed by incubation at 67˚C for 15 min.
Both Input and FAIRE samples were then extracted with 200 μl phenol:chloroform:isoamy-
lalcohol (25:24:1) and the aqueous layer retained. DNA was precipitated by conventional
methods and the pellet resuspended in 50–150 μl 50 mM Tris-HCl, pH 7.4, 10 mM EDTA.
Table 1. Primer pairs used for ChIP and FAIRE analysis of HPV18 genomes.
Amplicon midpoint� Forward Primer (50-30) Reverse Primer (50-30)
–3,886 TATGTGTGCTGCCATGTCCC CTGTGGCAGGGGACGTTATT
–3,352 GGGGTCGTACAGGGTACATT GATGTTATATCAAACCCAGACGTG
–2,384 TCTGCCTCTTCCTATAGTAATGTAACG GGAATAAAATAATATAATGGCCACAAA
–2,092 CCTCCTTCTGTGGCAAGAGT GGTCAGGTAACTGCACCCTAA
–1,198 AGTCTCCTGTACCTGGGCAA AACACCAAAGTTCCAATCCTCT
–556 GTGTGTTATGTGGTTGCGCC GGATGCTGTAAGGTGTGCAG
–57 ACTTTCATGTCCAACATTCTGTCT ATGTGCTGCCCAACCTATTT
155 TGTGCACGGAACTGAACACT CAGCATGCGGTATACTGTCTC
751 CGAACCACAACGTCACACAAT ACGGACACACAAAGGACAGG
943 AGTGTGAAGCCAGAATTGAGC ACCACGGACACACAAAGGA
1,500 GCAATGTATGTAGTGGCGGC TACACTGCTGTTGTTGCCCT
2,200 TTATAGGCGAGCCCAAAAAC CCAATCTCCCCCTTCATCTAT
2,819 TGCAGACACCGAAGGAAACC CATTTTCCCAACGTATTAGTTGCC
2,989 GGCAACTAATACGTTGGGAAAA TGTCTTGCAGTGTCCAATCC
3,165 AGGTGGCCAAACAGTACAAGT GCCGTTTTGTCCCATGTTCC
3,488 TGGGAAGTACATTTTGGGAATAA TCCACAGTGTCCAGGTCGT
All primer pairs generated a single product as determined by dissociation curve analysis.
�Primer midpoint is stated relative to the 7857/1 nucleotide position on the HPV18 episome (Genbank: AY262282.1).
Abbreviations: ChIP, chromatin immunoprecipitation; FAIRE, formaldehyde-assisted isolation of regulatory elements; HPV, human papillomavirus.
https://doi.org/10.1371/journal.pbio.2005752.t001
Table 2. Primer sequences for qRT-PCR transcript analysis.
Primer Pair Forward Sequence (50-30) Reverse Sequence (50-30)
E6/E7 (121–295) ATCCAACACGGCGACCCTAC GCAGCATGCGGTATACTGTCTCTA
E6 (131–180) GCGACCCTACAAGCTACCTG GCAGTGAAGTGTTCAGTTCCG
CTCF (exon 5–6) ATGTGCGATTACGCCAGTGTA TGAAACGGACGCTCTCCAGTA
β-actin GCTGTGCTATCCCTGTACGC CAGGAAGGAAGGCTGGAAGA
Abbreviations: CTCF, CCCTC-binding factor; qRT-PCR, quantitative reverse transcriptase-PCR.
https://doi.org/10.1371/journal.pbio.2005752.t002
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Recovery of FAIRE-extracted DNA in comparison to Input DNA was then determined by
qPCR using the ΔΔCT method. Primer sequences are shown in Table 1.
3C
A total of 1–1.5 × 107 cells were trypsinised and resuspended in 1 ml 10% (v/v) FCS/PBS. Cells
were passed through a 70 μm cell strainer and 9.5 ml of 1% formaldehyde in 10% FCS/PBS
added before incubation for 10 min at RT with end-to-end rotation. Glycine was added to a
final concentration of 125 μM before the cells were pelleted at 4˚C. Cells were resuspended in
5 ml of ice cold lysis buffer (10 mM Tris-HCl, pH 7.7, 10 mM NaCl, 5 mM MgCl2, 0.1 mM
EGTA, protease inhibitors) and incubated on ice for 10 min. Samples were centrifuged at 400
× g for 5 min at 4˚C to pellet the nuclei. Five hundred μl 1.2× restriction enzyme buffer and
0.3% (final concentration) SDS were added and samples incubated at 37˚C for 1 hr while shak-
ing at 900 rpm. Fifty μl of 20% Triton X-100 was then added, followed by incubation at 37˚C
for 1 hr with shaking at 900 rpm. Prior to digestion, an aliquot was removed for assessment of
digestion efficiency. Four hundred units of NlaIII restriction enzyme were added, and the sam-
ples were incubated at 37˚C overnight with shaking at 900 rpm. An aliquot of each sample was
removed and assessment of digestion efficiency performed by adding 500 μl of 5 mM EDTA,
pH 8.0, 10 mM Tris-HCl, pH 8.0, 0.5% SDS, and 20 μg proteinase K and incubating at 65˚C
for 30 min. One μg RNase A was added, followed by incubation at 37˚C for 2 hr. The DNA
was extracted with PCI and ethanol precipitated using conventional methods and the pellet
resuspended in 60 μl dH20. Digestion efficiency of the viral genomes was assessed by qPCR of
genome regions sensitive and insensitive to containing NlaIII restriction sites (Table 3) and
comparison of CT values as described in [59].
For ligation, 40 μl of 20% SDS was added to the samples, followed by incubation for 25 min
at 65˚C with shaking at 900 rpm. A total of 6.125 ml 1.15× ligation buffer and 1% (final con-
centration) Triton X-100 was added. Samples were incubated for 1 hr at 37˚C with gentle shak-
ing. One hundred units of T4 DNA ligase were added and the samples incubated for 4 hr at
16˚C, followed by 30 min at RT. Three hundred μg proteinase K was added, and the samples
were incubated at 65˚C overnight.
To purify the digested DNA, 300 μg RNase A was added and the samples incubated for 45
min at 37˚C. The DNA was extracted with PCI twice and ethanol precipitated. Finally, the
DNA pellet was resuspended in 10 mM Tris-HCl, pH 7.5. Ligation of specific regions of the
HPV18 genome was assessed by PCR using sense primers specific to the L1 and E2 ORFs to
detect interactions between the CTCF-bound E2 ORF and the viral LCR and sense primers
specific for the L2 and E2 ORFs to detect ligation events that could occur by chance (Table 3).
PCR products were assessed by agarose gel electrophoresis and compared to products obtained
with a synthesised DNA template equivalent to the predicted ligation product (GeneStrings).
Products were sequenced and quantified with a Fusion FX imaging system.
Table 3. Primers used for 3C analysis of HPV18 genomes.
Primer Pair Forward Primer (50-30) Reverse Primer (50-30)
E2–CTCF (�) N/A CTTGCAGTGTCCAATCCTCG
LCR–YY1 (1) N/A GGTGCAGCATCCTTTTGACA
L2 (2) N/A CCCCGTACCAGAAGAAGCAA
E1 (3 and 4) AGTGTGAAGCCAGAATTGAGC ACCACGGACACACAAAGGA
HPV18 Digest efficiency GCAAACGGGCTTCGGTAACT TTATCTGCTAACGTGGTGCCC
Abbreviations: CTCF, CCCTC-binding factor; HPV, human papillomavirus; LCR, long control region; YY1, Yin Yang 1; 3C, chromosome conformation capture.
https://doi.org/10.1371/journal.pbio.2005752.t003
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Lentiviral transduction of keratinocytes and shRNA expression
Human embryonic kidney 293T (HEK293T) cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% FBS and transfected with second-generation lenti-
viral packaging plasmids, psPAX2 and pMD2.G, and pTRIPZ-shRNA expressing plasmid
using polyethylenimine (PEI) Max at a DNA-to-reagent ratio of 1:3. Medium containing lenti-
viral particles was recovered at 48 and 72 hr post transfection and passed through a 0.45 μM fil-
ter. The resulting recombinant lentiviruses were concentrated using Vivaspin ultrafiltration
spin columns (50,000 MWCO PES) and used to spin infect HPV18-genome–containing kera-
tinocytes growing in 6-well plates in E medium containing 8 μg/ml polybrene after feeders had
been removed. Plates were spun at 3,220 × g for 90 min to facilitate infection, after which
media were replaced with E medium. Twenty-four hr later, lentiviral infection was repeated as
described above before cells were detached and seeded onto fresh irradiated feeder cells in 10
cm dishes. Puromycin to a final concentration of 1 μg/ml was added to the cells 72 hr later to
select infected cells. shRNA expression was induced with 1 μg/ml doxycycline for 48 hr.
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